Reading SRTA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRTA free→Reading SRTA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRTA free→QuarterlyIQ Insights · SRTA
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 6, 2026, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the first quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Results of Operations and Financial Condition. On March 3, 2026, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Regulation FD Disclosure. On February 5, 2026, the Company issued a press release announcing the transactions contemplated by the Credit Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01, including the corresponding Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject…
Entry into a Material Definitive Agreement. The Credit Agreement On January 30, 2026 (the “Closing Date”), Strata Critical Medical, Inc. (the “Company”), Strata Critical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Critical”), Trinity Air Medical, LLC, an Arizona limited liability company and wholly owned subsidiary of Critical (“Trinity Air”), Keystone Perfusion Services, LLC, a Pennsylvania limited liability company and wholly owned subsidiary of Critical (“Key…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 2, 2025, the board of directors (the “Board”) of Strata Critical Medical, Inc. (the “Company”) expanded the size of the Board from eight directors to nine directors and appointed William L. Cook, III to serve as a Class I director, effective immediately, with a term expiring at the Company’s 2027 annual meeting of stockholders. The Boar…
Completion of Acquisition or Disposition of Assets The information set forth in the “Explanatory Note” of this Amendment is incorporated by reference into this
Results of Operations and Financial Condition. On November 10, 2025, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Entry into a Material Definitive Agreement. On September 16, 2025, Strata Critical Medical, Inc., a Delaware corporation (“Strata” or the “Company”), entered into a Purchase and Sale Agreement (the “Purchase Agreement”) among Strata Critical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (the “Buyer”), Keystone Perfusion Services, LLC, a Pennsylvania limited liability company (“Keystone”), LRV Holdco, Inc., a Delaware corporation (“Seller”), the Louis Verdetto Irrevo…
The Company will file with the SEC the financial statements and pro forma financial information required to be filed pursuant to
Regulation FD Disclosure. On September 16, 2025, the Company issued a press release announcing the transactions contemplated by the Purchase Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01, including the corresponding Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise sub…
The Company issued 3,434,607 of Company Shares in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506(b) of Regulation D promulgated thereunder.
Completion of Acquisition or Disposition of Assets. On August 29, 2025, the Company completed the previously announced sale of its Passenger business to Joby Aero, Inc. (“Joby Buyer”) pursuant to that certain Equity Purchase Agreement, dated as of August 1, 2025 (the “Purchase Agreement”), among the Company, Strata Critical, Inc. (f/k/a Trinity Medical Intermediate II, Inc.), a wholly owned subsidiary of the Company, Blade Urban Air Mobility, LLC (f/k/a Blade Urban Air Mobility, Inc.), Joby A…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously announced, effective as of the consummation of the transactions contemplated by that certain Equity Purchase Agreement, dated as of August 1, 2025, among the Company and the other parties thereto (the “Closing”), Melissa Tomkiel, who previously served as the Company’s President and General Counsel, and William Heyburn, who previously…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously announced, effective as of the Closing, Melissa Tomkiel, who previously served as the Company’s President and General Counsel, and William Heyburn, who previously served as the Company’s Chief Financial Officer and Head of Corporate Development, assumed the roles of co-Chief Executive Officers of the Company. Ms. Tomkiel will continue…
Entry into a Material Definitive Agreement. The information set forth under
Results of Operations and Financial Condition On August 5, 2025, Blade Air Mobility, Inc. (“Blade”) issued a press release announcing its financial results for the second quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Management Transition In connection with the execution of the Purchase Agreement, the Company entered into a Transition and Transaction Bonus Agreement, dated August 1, 2025 (the “Transition Agreement”), with the Company’s Chief Executive Officer, Robert Wiesenthal. Pursuant to the Transition Agreement, effective as of the Closing, Mr. Wiesenthal’s…
Entry into a Material Definitive Agreement. On August 1, 2025, Blade Air Mobility, Inc., a Delaware corporation (“Blade” or the “Company”), entered into an Equity Purchase Agreement (the “Purchase Agreement”) among the Company, Trinity Medical Intermediate II, Inc., a Delaware corporation and wholly owned subsidiary of the Company, Blade Urban Air Mobility, Inc., a Delaware corporation and wholly owned subsidiary of the Company, Joby Aviation, Inc., a Delaware corporation (“Joby Aviation”), a…
Results of Operations and Financial Condition On May 12, 2025, Blade Air Mobility, Inc. (“Blade”) issued a press release announcing its financial results for the first quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Results of Operations and Financial Condition On March 13, 2025, Blade Air Mobility, Inc. (“Blade”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.